Sartorius Stedim BiotechSRTOY -1.61%82 Median PS Value is $32.38 as of Jun. 26, 2026, which is 4882% above its 10-year median of 0.65. GuruFocus rates SRTOY with a GF Score™ of 82/100 and a GF Value™ of $23.93 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 338 Medical Devices & Instruments companies, Sartorius Stedim Biotech ranks better than 59.76% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Sartorius Stedim Biotech's Median PS Value or its related term are showing as below:
SRTOY'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.44 Med: 0.65 Max: 1.38
Current: 0.61
During the past 13 years, the highest Price to Median PS Value of Sartorius Stedim Biotech was 1.38. The lowest was 0.44. And the median was 0.65.
SRTOY's Price-to-Median-PS-Value is ranked better than 59.76% of 338
companies
in the Medical Devices & Instruments industry
Industry Median: 0.71
vs SRTOY: 0.61
Sartorius Stedim Biotech (OTCPK:SRTOY) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Sartorius Stedim Biotech's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
19.865
/
32.38
=
0.61
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sartorius Stedim Biotech Median PS Value Related Terms
Sartorius Stedim Biotech Median PS Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SRTOY vs ISRG, BDX, MDLN: Median PS Value Comparison
For the Medical Instruments & Supplies subindustry, Sartorius Stedim Biotech's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sartorius Stedim Biotech Price-to-Median-PS-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sartorius Stedim Biotech's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Sartorius Stedim Biotech's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 9.093.
Sartorius Stedim Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.561.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sartorius Stedim Biotech (SRTOY) has a Median PS Value of $32.38 as of Jun. 26, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Sartorius Stedim Biotech and its competitors. This is 4882% above median its historical median of 0.65. Over the past decade, Sartorius Stedim Biotech's Median PS Value has ranged from 0.44 to 1.38. According to the industry distribution chart, Sartorius Stedim Biotech ranks #136 out of 338 companies in the Medical Devices & Instruments industry, placing it in the top 40.2%.
Is Sartorius Stedim Biotech's Median PS Value too high?
Sartorius Stedim Biotech's current Median PS Value of $32.38 is 4882% above median its 10-year median of 0.65. Over the past 10 years, this metric has ranged from a low of 0.44 to a high of 1.38. The Medical Devices & Instruments industry median Median PS Value is 0.71. Sartorius Stedim Biotech's value of $32.38 is 4460.6% above this industry median. Based on the distribution chart, Sartorius Stedim Biotech ranks #136 out of 338 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Sartorius Stedim Biotech has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sartorius Stedim Biotech's Median PS Value compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Sartorius Stedim Biotech ranks #136 out of 338 companies for Median PS Value. This puts Sartorius Stedim Biotech in the upper half of its industry. The industry median Median PS Value is 0.71. Sartorius Stedim Biotech's value of $32.38 is 4460.6% above this benchmark. Historically, Sartorius Stedim Biotech's own Median PS Value has ranged from 0.44 to 1.38 over the past decade. While the company's 10-year median is 0.65 vs. the industry median of 0.71, Sartorius Stedim Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Devices & Instruments company?
The median Median PS Value among Medical Devices & Instruments companies is 0.71, based on 338 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sartorius Stedim Biotech's current Median PS Value of $32.38 is 4460.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Sartorius Stedim Biotech and its competitors. For the Medical Devices & Instruments industry, the median Median PS Value is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sartorius Stedim Biotech's current Median PS Value is $32.38, which is 4882% above median its own 10-year median of 0.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sartorius Stedim Biotech stock overvalued right now?
Based on GuruFocus' analysis, Sartorius Stedim Biotech (SRTOY) is currently considered Modestly Undervalued. The stock's GF Value™ is $23.93, compared to a current price of $19.87 — trading 17% below its estimated fair value. The current Median PS Value is $32.38, which is 4882% above median its 10-year median of 0.65 and 4460.6% above the Medical Devices & Instruments industry median of 0.71. Sartorius Stedim Biotech's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Sartorius Stedim Biotech (SRTOY), the current Median PS Value is $32.38 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sartorius Stedim Biotech (SRTOY) Overvalued in 2026?
Based on GuruFocus' analysis, Sartorius Stedim Biotech stock appears to be undervalued.
The current stock price of $19.87 is trading 17% below its estimated GF Value™ of $23.93.
GuruFocus considers Sartorius Stedim Biotech to be Modestly Undervalued.
Key valuation signals for SRTOY:
Median PS Value: $32.38 (4882% above median its 10-year median of 0.65)
GF Value™: $23.93 vs. price of $19.87 (17% below fair value)
Industry Position: 4460.6% above the Medical Devices & Instruments median (#136 of 338)
No single metric tells the full story. See the SRTOY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sartorius Stedim Biotech is a leading provider of bioprocessing solutions. It sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs and has a focus on single-use technology. It is a subsidiary of Sartorius AG, which has 71.5% ownership and 83% voting control. The business is geographically diverse, with 35% of sales from the Americas, 42% from Europe, the Middle East, and Africa, 15% from Asia excluding China, and 8% from China.
82GF Score
Get the complete analysis for SRTOY
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SRTOY has been successfully added to your 
